Diligence memo · auto-generated · as of July 2, 2026
Matthias Therapeutics, LLC
Matthias Therapeutics, LLC looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Matthias Therapeutics, LLC operates in Pharmaceuticals, based in BASKING RIDGE.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Matthias Therapeutics, LLC has raised $100K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $100K on 2025-11-24.
Most recent recorded round closed around 2025-11-24.
Valuation (modeled)modeled
Provath models Matthias Therapeutics, LLC at approximately $199K (range $56K–$439K). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.14× the median modeled value of Pre-Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 7 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 1% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 0% of those peers.
Closest niche peers: Fedora Pharmaceuticals Inc., PRG FlowChem, Inc., Adora Animal Health Corp, ABLi Therapeutics, Inc., NextEvo, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.